These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6420528)

  • 1. A comparative economic analysis of work-related hypertension care programs.
    Ruchlin HS; Melcher LA; Alderman MH
    J Occup Med; 1984 Jan; 26(1):45-9. PubMed ID: 6420528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a worksite hypertension treatment program.
    Logan AG; Milne BJ; Achber C; Campbell WP; Haynes RB
    Hypertension; 1981; 3(2):211-8. PubMed ID: 6783519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of work-site blood pressure control programs.
    Erfurt JC; Foote A
    J Occup Med; 1984 Dec; 26(12):892-900. PubMed ID: 6439841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefit to cost ratio of work-site blood pressure control programs.
    Foote A; Erfurt JC
    JAMA; 1991 Mar; 265(10):1283-6. PubMed ID: 1899894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small, blue collar work site hypertension screening: a cost-effectiveness study.
    Ellis E; Koblin W; Irvine MJ; Legare J; Logan AG
    J Occup Med; 1994 Mar; 36(3):346-55. PubMed ID: 8195906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
    Milani RV; Lavie CJ
    Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypertension treatment program at the workplace to complement community care.
    Sexton M; Yuhas MK; Guyther JR
    Prev Med; 1985 Jan; 14(1):15-23. PubMed ID: 4034511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of work-site wellness programs for hypertension control, weight loss, and smoking cessation.
    Erfurt JC; Foote A; Heirich MA
    J Occup Med; 1991 Sep; 33(9):962-70. PubMed ID: 1744745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-benefit study of a hypertension screening and treatment program at the work setting.
    Hannan EL; Graham JK
    Inquiry; 1978 Dec; 15(4):345-48. PubMed ID: 152293
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of a worksite clinic: is it worth the cost?
    Chenoweth DH; Garrett J
    AAOHN J; 2006 Feb; 54(2):84-9; quiz 90-1. PubMed ID: 16509183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community control of hypertension at the worksite in a metallurgical factory: results of 1-year follow-up.
    Fogari R; Poletti L; Tettamanti F; Daglio M; Zoppi AL
    Eur J Epidemiol; 1989 Jun; 5(2):164-9. PubMed ID: 2767224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using an ounce of prevention: does it reduce health care expenditures and reap pounds of profits? A study of the financial impact of wellness and health risk screening programs.
    Phillips JF
    J Health Care Finance; 2009; 36(2):1-12. PubMed ID: 20499716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projecting future medical care costs using four scenarios of lifestyle risk rates.
    Leutzinger JA; Ozminkowski RJ; Dunn RL; Goetzel RZ; Richling DE; Stewart M; Whitmer RW
    Am J Health Promot; 2000; 15(1):35-44. PubMed ID: 11184117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness and cost-effectiveness of monitoring blood pressure of hypertensive employees at work.
    Logan AG; Milne BJ; Flanagan PT; Haynes RB
    Hypertension; 1983; 5(6):828-36. PubMed ID: 6418647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
    Borenstein JE; Graber G; Saltiel E; Wallace J; Ryu S; Archi J; Deutsch S; Weingarten SR
    Pharmacotherapy; 2003 Feb; 23(2):209-16. PubMed ID: 12587810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of employee health improvement programs.
    Fielding JE
    J Occup Med; 1982 Nov; 24(11):907-16. PubMed ID: 6816911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):301-9. PubMed ID: 10661043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses' intervention in specific risk factors in high risk employees. An economic appraisal.
    Chenoweth D
    AAOHN J; 1989 Sep; 37(9):367-73. PubMed ID: 2505784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupationally-sponsored, community-provided hypertension control.
    Alderman MH; Melcher LA
    J Occup Med; 1983 Jun; 25(6):465-70. PubMed ID: 6886849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.